Literature DB >> 23052899

[Prevalence of arterial hypertension in the population of Western Germany: Heinz Nixdorf Recall Study].

M Horacek1, S Möhlenkamp, A A Mahabadi, S Churzidse, S Moebus, K-H Jöckel, R Erbel.   

Abstract

Regional disparities in the prevalence of arterial hypertension in Germany have been reported in population-based surveys. An analysis comparing the SHIP study in the north-eastern region of Germany (1997-2001) with the MONICA/KORA-S4 study (1999-2001) in the south-west of Germany showed a significantly higher age-adjusted prevalence in the north-eastern population. The Heinz Nixdorf Recall Study is a population based prospective cohort study designed to assess cross-sectional and longitudinal data of risk factors, subclinical signs of atherosclerosis and cardiovascular endpoints in the Ruhr area of Germany. A total of 4,443 subjects without coronary artery disease aged 45-75 years could be included between 2000 und 2003 and the prevalence of hypertension, defined by JNC-7, was 63% in men and 52% in women. Low rates of hypertension awareness, treatment and control rates in population-based surveys as well as in recently published high risk cohorts with known coronary artery disease in Germany elucidate the need to optimize the strategies of screening, treatment and follow-up in primary and secondary prevention. Coronary artery calcification was demonstrated to be an independent risk factor for cardiovascular endpoints even in the stage of prehypertension. The risk-benefit ratio for an early treatment of these patients could be improved by advanced risk stratification, assessing the level of coronary artery calcification.

Entities:  

Mesh:

Year:  2012        PMID: 23052899     DOI: 10.1007/s00059-012-3684-z

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  36 in total

1.  Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle.

Authors:  Axel Schmermund; Stefan Möhlenkamp; Andreas Stang; Dietrich Grönemeyer; Rainer Seibel; Herbert Hirche; Klaus Mann; Winfried Siffert; Karl Lauterbach; Johannes Siegrist; Karl-Heinz Jöckel; Raimund Erbel
Journal:  Am Heart J       Date:  2002-08       Impact factor: 4.749

2.  ZERO-MUDDLER FOR UNPREJUDICED SPHYGMOMANOMETRY.

Authors:  J S GARROW
Journal:  Lancet       Date:  1963-12-07       Impact factor: 79.321

3.  [Study of Health in Pomerania (SHIP). Concept, design and selected results].

Authors:  H Völzke
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2012-06       Impact factor: 1.513

4.  New and classical risk factors--the Münster heart study (PROCAM).

Authors:  G Assmann; H Schulte; P Cullen
Journal:  Eur J Med Res       Date:  1997-06-16       Impact factor: 2.175

5.  Does the Hawksley random zero sphygmomanometer underestimate blood pressure, and by how much?

Authors:  A Mackie; P Whincup; M McKinnon
Journal:  J Hum Hypertens       Date:  1995-05       Impact factor: 3.012

6.  [Blood pressure in Germany--current status and trends].

Authors:  M Thamm
Journal:  Gesundheitswesen       Date:  1999-12

7.  Baseline recruitment and analyses of nonresponse of the Heinz Nixdorf Recall Study: identifiability of phone numbers as the major determinant of response.

Authors:  A Stang; S Moebus; N Dragano; E M Beck; S Möhlenkamp; A Schmermund; J Siegrist; R Erbel; K H Jöckel
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

8.  Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study.

Authors:  Raimund Erbel; Stefan Möhlenkamp; Susanne Moebus; Axel Schmermund; Nils Lehmann; Andreas Stang; Nico Dragano; Dietrich Grönemeyer; Rainer Seibel; Hagen Kälsch; Martina Bröcker-Preuss; Klaus Mann; Johannes Siegrist; Karl-Heinz Jöckel
Journal:  J Am Coll Cardiol       Date:  2010-10-19       Impact factor: 24.094

9.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

10.  Determinants of disease and disability in the elderly: the Rotterdam Elderly Study.

Authors:  A Hofman; D E Grobbee; P T de Jong; F A van den Ouweland
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

View more
  1 in total

1.  [Blood pressure measurement in the NAKO German National Cohort (GNC) - differences in methods, distribution of blood pressure values, and awareness of hypertension compared to other population-based studies in Germany].

Authors:  Tamara Schikowski; Claudia Wigmann; Kateryna B Fuks; Sabine Schipf; Margit Heier; Hannelore Neuhauser; Giselle Sarganas; Wolfgang Ahrens; Heiko Becher; Klaus Berger; Hermann Brenner; Stefanie Castell; Antje Damms-Machado; Marcus Dörr; Nina Ebert; Ljupcho Efremov; Carina Emmel; Stephan B Felix; Beate Fischer; Claus-Werner Franzke; Sylvia Gastell; Kathrin Günther; Johannes Haerting; Till Ittermann; Lina Jaeschke; Annika Jagodzinski; Karl-Heinz Jöckel; Rudolphe Kaaks; Sonja Kalinowski; Thomas Keil; Yvonne Kemmling; Alexander Kluttig; Lilian Krist; Oliver Kuss; Nicole Legath; Michael Leitzmann; Wolfgang Lieb; Markus Löffler; Claudia Meinke-Franze; Karin B Michels; Rafael Mikolajczyk; Susanne Moebus; Sebastian Nuding; Annette Peters; Tobias Pischon; Ina-Maria Rückert-Eheberg; Ben Schöttker; Börge Schmidt; Carsten Oliver Schmidt; Matthias B Schulze; Andreas Stang; Inke Thiele; Sigrid Thierry; Barbara Thorand; Henry Völzke; Sabina Waniek; Karl Werdan; Kerstin Wirkner; Karin Halina Greiser
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-04       Impact factor: 1.513

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.